Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: szelevente

May 28, 2019 E-ducation

Carbohydrate drugs (Part 4) (Oligosaccharides, antibiotics)

In the next two posts we’ll take a closer look to the oligosaccharides (generally composed from 3 to 10 monosaccharide

Continue reading

May 22, 2019 E-ducation

Carbohydrate drugs (Part 3) (Disaccharides)

In the previous posts we talked a little bit about monosaccharide type active pharmaceutical ingredients. The next are disaccharides: composed of

Continue reading

May 15, 2019 E-ducation

Carbohydrate drugs (Part 2) (iminosugars and rare diseases)

  In the part 1 we talked about monosaccharides used for the treatment of common diseases, like influenza or angina

Continue reading

May 13, 2019 E-ducation

Carbohydrate drugs (Part 1)

As we know, cyclodextrins are composed of α-D-glucopyranose units. Among pharmaceuticals there are several other carbohydrate type drugs. In this

Continue reading

February 11, 2019 Drug delivery / Pharma applications

Cyclodextrins in veterinary medicine (Part 2)

In our previous post we talked about the “classical” usage of cyclodextrins in veterinary medicine. Now let’s see some non-usual

Continue reading

January 28, 2019 Drug delivery / Pharma applications

Cyclodextrins in veterinary medicine (Part 1)

It is well known, that cyclodextrins have many different applications. Can they be used in veterinary medicine? Well, yes and

Continue reading

Posts pagination

«Previous Posts 1 2 3

Recent Posts

  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • A cyclodextrin polymer that could change the future of batteries
  • Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral Inhibition
  • 15th International Conference on Biomedical Engineering and Biotechnology
  • Tailoring cyclodextrin platforms for nanomolar range fluorescence detection of 1-hydroxypyrene as biomarker of polycyclic aromatic hydrocarbons

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (74)
  • CD as API (357)
  • CD derivatives (434)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (817)
  • E-ducation (63)
  • Environmental (144)
  • Events (240)
  • Food (234)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (417)
  • Other industrial use (113)
  • Pharma applications (1,222)
  • Supramolecular systems (44)
  • Uncategorized (168)

Top Posts

  • Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
  • A cyclodextrin polymer that could change the future of batteries
  • The Impact and Prospects of Green Chemistry for Textile Technology
  • Tailoring cyclodextrin platforms for nanomolar range fluorescence detection of 1-hydroxypyrene as biomarker of polycyclic aromatic hydrocarbons
  • Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral Inhibition
  • FDA grants approval to Axsome Therapeutics' migraine medication containing Betadex Sulfobutylether Sodium
  • Pilocarpine eye drops (Vuity)
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Cyclodextrin polymers containing ionizable and ionic groups: A comprehensive review from classifications and synthesis methods to applications.
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...